Articles from Prolocor Inc

Prolocor Announces the Publication of Two Important New Analyses from a Recently Completed Clinical Study
In JACC: Advances, high platelet FcɣRIIa (pFCG) identified patients at greater risk of multiple, recurrent cardiovascular events.
By Prolocor Inc · Via ACCESS Newswire · July 20, 2026
Articles from Prolocor Inc | FWNBC